The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis  Anjuli S. Nayak, MDa, Mark H.

Slides:



Advertisements
Similar presentations
Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane- beclomethasone extrafine inhalation aerosol), in asthma Jennifer.
Advertisements

Reducing relative humidity to control the house dust mite Dermatophagoides farinae Larry G. Arlian, PhD, Jacqueline S. Neal, BS, DiAnn L. Vyszenski-Moher,
W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc 
Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome  Paul Steinberg, MDa, Bruce E.
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
A clinical analysis of gelatin allergy and determination of its causal relationship to the previous administration of gelatin-containing acellular pertussis.
Ulrich Wahn, MDa. ‡, Eli O. Meltzer, MDb. ‡, Albert F. Finn, MDc
Zafirlukast improves asthma symptoms and quality of life in patients with moderate reversible airflow obstruction  Robert A. Nathan, MDa, Jonathan A.
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis  William R. Lumry, MD  Journal of.
A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children  Mark Boguniewicz, MDa, Virginia C. Fiedler,
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis 
Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis  Paul H. Ratner,
Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: Results of recent clinical trials  Javier Dibildox,
Practice Notes from the AAAI
Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma  B.Lauren Charous, MD, Elkan F. Halpern,
Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis  James.
Product characteristics and pharmacokinetics of intranasal ipratropium bromide  Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.
Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W
Elinor Simons, MDa, William M
Elephantiasis nostras: A case report
Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol  Henry Milgrom, MDa, David P. Skoner,
Conjunctivitis medicamentosa
Serum levels of eosinophil cationic protein in allergic diseases and natural allergen exposure  Margherita Tomassini, MDa, Laura Magrini, MDa, Guido De.
Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid–dependent, persistent asthma  Gail.
Anaphylactic reaction to local administration of rifamycin SV
Practice Notes from the AAAAI
Allergic rhinoconjunctivitis caused by Harmonia axyridis (Asian lady beetle, Japanese lady beetle, or lady bug)  John A. Yarbrough, MDa, Jack L. Armstrong,
Joseph T. DiPiro, PharmDa, b, Thomas R. Howdieshell, MDb, Robert G
A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model  John M.
A review of the current guidelines for allergic rhinitis and asthma
Physician-targeted program on inhaled therapy for childhood asthma
Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: Effects of single allergen challenge  Adriaan.
News & Notes Journal of Allergy and Clinical Immunology
Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype  Atsuko Takao, MDa, Terufumi Shimoda, MDa, Shigeru Kohno, MDa, Sadahiro.
James P. Kemp, MDa, David A. Cook, MDb, Gary A
Selective allergic reactions to clavulanic acid
Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.
News Beyond Our Pages Journal of Allergy and Clinical Immunology
Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray  Eli O. Meltzer,
Jack M. Becker, MDa, Anjali Arora, MDb, Richard J
F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc 
Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients.
Thomas B. Casale, MDa, I. Leonard Bernstein, MDb, William W
A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma  Gordon D. Raphael, MDa, Robert.
News & Notes Journal of Allergy and Clinical Immunology
Fluticasone propionate powder: Oral corticosteroid–sparing effect and improved lung function and quality of life in patients with severe chronic asthma 
A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray 
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma  Eugene R. Bleecker, MDa, Michael J. Welch, MDb,
Occupational allergy caused by urticating hair of Brazilian spider
Omalizumab improves asthma-related quality of life in patients with severe allergic asthma  Albert Finn, MDa, Gary Gross, MDb, Julius van Bavel, MDc,
The 30th anniversary of the American Board of Allergy and Immunology: Then and now  Lynn Des Prez a, Charles E. Reed, MD, Lawrence B. Schwartz, MDb, John.
A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room  Dann K. Heilman,
Steroid-sparing effects of fluticasone propionate 100 μg and salmeterol 50 μg administered twice daily in a single product in patients previously controlled.
The role and remediation of animal allergens in allergic diseases
Chemokines in seasonal allergic rhinitis
The effect of anti-IgE treatment on in vitro leukotriene release in children with seasonal allergic rhinitis  Matthias Volkmar Kopp, MDa, Jens Brauburger,
Practice Notes from the AAAI
Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing.
Anaphylaxis after initial ingestion of rambutan, a tropical fruit
Terence J. Furlong, MSa, Jennifer DeSimonea, Scott H. Sicherer, MDb 
In vitro detection of specific IgE antibodies to erythromycin
Footnotes1 Journal of Allergy and Clinical Immunology
Evelyn Farinas, RPh, MGA, Peter Honig, MD 
The environmental predictors of allergic disease
Bruce K. Bacot, MD, Mary E. Paul, MD, Maritza Navarro, MD, Stuart L
Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial  Eli O. Meltzer, MDa,
News & Notes Journal of Allergy and Clinical Immunology
Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal.
Clinical relevance of inhaled corticosteroids and HPA axis suppression
Presentation transcript:

The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis  Anjuli S. Nayak, MDa, Mark H. Ellis, MDb, Gary N. Gross, MDc, Louis M. Mendelson, MDd, Eric J. Schenkel, MDe, Bobby Q. Lanier, MDf, Brandon Simpson, BSg, Mary Ellen Mullin, MTg, Joseph A. Smith, MDH  Journal of Allergy and Clinical Immunology  Volume 101, Issue 2, Pages 157-162 (February 1998) DOI: 10.1016/S0091-6749(98)70379-3 Copyright © 1998 Mosby, Inc. Terms and Conditions

FIG. 1 Pretreatment mean plasma cortisol levels (μg/dl) at prestimulation (0 hour) and 30 and 60 minutes after cosyntropin stimulation. Journal of Allergy and Clinical Immunology 1998 101, 157-162DOI: (10.1016/S0091-6749(98)70379-3) Copyright © 1998 Mosby, Inc. Terms and Conditions

FIG. 2 Pretreatment and posttreatment (6 weeks) mean plasma cortisol levels (μg/dl) at prestimulation (0 hour) and 30 and 60 minutes after cosyntropin stimulation. Journal of Allergy and Clinical Immunology 1998 101, 157-162DOI: (10.1016/S0091-6749(98)70379-3) Copyright © 1998 Mosby, Inc. Terms and Conditions

FIG. 3 Mean TAA plasma concentration-time curve. Journal of Allergy and Clinical Immunology 1998 101, 157-162DOI: (10.1016/S0091-6749(98)70379-3) Copyright © 1998 Mosby, Inc. Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.